Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
Live webcast on Wednesday, June 25th at 12:00 PM ET
ISELIN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will participate in a Virtual Investor Lunch Break Event on Wednesday, June 25, 2025 at 12:00 PM ET.
As part of the event, Lawrence Kenyon, Chief Financial Officer and Interim Chief Executive Officer, Jeff Evanson, Chief Commercial Officer and Jedd Comiskey, Senior VP – Head of Europe, will discuss the Company's commercial strategy, upcoming milestones and current activities. In addition to the moderated discussion, investors and interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible in the time allowed.
A live video webcast will be available on the Events page under the Investors section of the Company's website (outlooktherapeutics.com). A webcast replay will be available two hours following the live event and will be accessible for 90 days.About Outlook Therapeutics, Inc.
Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg; bevacizumab gamma) to enhance the standard of care for bevacizumab for the treatment of retina diseases. LYTENAVA™ (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD.
In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational, and a BLA has been resubmitted to the FDA. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD.
Investor Inquiries:
Jenene ThomasChief Executive OfficerJTC Team, LLCT: 908.824.0775OTLK@jtcir.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
American Express Plans Live Audio Webcast of Second-Quarter 2025 Earnings Conference Call
NEW YORK--(BUSINESS WIRE)--American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, July 18, 2025, to discuss the company's second-quarter 2025 financial results. The webcast will be accessible to the general public through the American Express Investor Relations website at The financial results and presentation materials are scheduled to be released and posted on the website at approximately 7:00 a.m. (ET) prior to the conference call, and a webcast replay will be available on the website following the call. ABOUT AMERICAN EXPRESS American Express (NYSE: AXP) is a global, premium payments and lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services and experiences that enrich lives and build business success. Founded in 1850 and headquartered in New York, American Express' brand is built on trust, security, and service, and a rich history of delivering innovation and Membership value for our customers. With a hundred million merchant locations on our global network in around 200 countries and territories, we seek to provide the world's best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations. For more information about American Express, visit and Source: American Express Company Location: Global
Yahoo
36 minutes ago
- Yahoo
RED Mountain Appoints New President to Continue Fierce Independence and Authentic Mountain Vision
Headshot: Howard Katkov Headshot: Mark Schroetel ROSSLAND, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) -- RED Mountain Resort, one of North America's last great independent ski resorts, today announces a major leadership transition that marks both the culmination of a 22-year legacy and the beginning of a bold new era. After more than two decades at the helm, Howard Katkov, RED's long-time CEO who has successfully led RED's strategy of growth to preserve the resort's fierce independence without disenfranchising the community of Rossland, will step down from his role as Chief Executive Officer. Katkov will continue to serve as Chairman of the Board, ensuring that RED's ethos remains intact. Simultaneously, Don Thompson, President of RED Mountain Resort, will also transition out of his executive role while remaining an active member of the board. Following an extensive international search, RED is proud to welcome Mark Schroetel as its new President, effective July 6, 2025. With over 30 years of resort and industry leadership, Schroetel has a proven record of helping ski areas thrive—while staying true to their soul. 'For 22 years, I've poured my heart into this mountain,' said Howard Katkov. 'Not to build a cookie-cutter resort, but to protect something real. RED stands for independence, character, and community. I couldn't pass that legacy to just anyone. In Mark, I see someone who gets it—who understands that RED's success lies in its authenticity, not in conforming to the status quo. I'm thrilled to support him as we take RED into its next chapter.' A Career—and a Calling—25 Years in the Making Schroetel brings a rich and diverse background to RED. He served for 15 years as General Manager of Bear Creek Mountain Resort in Pennsylvania, where he oversaw a full-scale redevelopment of the resort. Later, he spent 8 years as General Manager and CEO at Utah's Powder Mountain, North America's largest skiable resort by acreage, where he helped define a differentiated skiing experience focused on preservation over profit. But for Schroetel, RED is more than a career move—it's personal. 'I've always been drawn to the Kootenays,' said Schroetel. 'In fact, I brought my dad here for his 60th birthday and returned to RED as a reward for completing my first year as a GM over two decades ago. When this opportunity came up, it felt like destiny. During a recent visit, my wife looked at me and said she's never seen me so happy in the 16 years we've been together. I responded, 'This is where I belong.'' 'I'm incredibly honored to join the team at RED and can't wait to put down roots in Rossland. This is more than a job—it's a commitment to community, to authenticity, and to keeping the dream of independent skiing alive." The Road Ahead Under Katkov's stewardship, RED has achieved legendary status: one of the Top 10 largest ski resorts in North America, with 3,850 acres of unspoiled terrain, nearly 3,000 feet of vertical, and legendary tree skiing across five peaks. RED has also embraced its next evolution as a true four-season destination, launching new summer experiences and deepening its ties to the local community. Most notably, the resort will officially open its highly anticipated Gravity Logic designed lift-accessed RED Mountain Bike Park on June 21, further demonstrating Katkov's vision to make RED a world-class mountain playground in all seasons. Schroetel's appointment is the next step in that evolution—ushering in a future built not on acquisition or homogenization, but on independence, innovation, and respect for the mountain and the community of Rossland. Media Contact:Chella Levesque | Chella Levesque Inc. | chella@ | 604.961.9185 About RED Mountain Resort: Fiercely independent and proudly rooted in Rossland, BC, RED Mountain Resort is Western Canada's oldest ski resort and one of North America's largest, offering 3,850 acres of terrain, nearly 3,000 feet of vertical, and legendary tree skiing across five peaks. Just minutes from the U.S. border in the Kootenays, RED blends rich heritage with bold innovation—including in-bounds cat skiing and a new lift-accessed bike park—making it a true four-season mountain playground with authentic mountain-town charm. About RED Mountain Homes: RED Mountain Homes was born from a deep commitment to stay true to the culture, roots, and spirit of RED Mountain Resort and Rossland. A collection of neighbourhoods located in and around the base of RED Mountain, minutes from Rossland's historic downtown, 30 minutes from Trail Regional Airport, and a two-and-a-half-hour drive from Spokane International Airport, each RED Mountain Homes development will offer access to the lifts for year-round mountain adventure and walkable, pedestrian-oriented streets. RED Mountain Homes was created for those who share the community's love of mountain living. Photos accompanying this announcement are available at:
Yahoo
36 minutes ago
- Yahoo
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward Growth
NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full compliance with Nasdaq's minimum bid price requirement. On June 18, 2025, the Company received formal notice from the Nasdaq Listing Qualifications Department confirming that Hoth's common stock closed at or above the $1.00 minimum bid price for 10 consecutive trading sessions—from June 4th through June 17- satisfying the requirement under Listing Rule 5550(a)(2). As a result, the compliance matter is officially closed. "Regaining Nasdaq compliance is a major milestone for Hoth and reflects growing market confidence in our strategy and pipeline," said Robb Knie, CEO of Hoth Therapeutics. "We believe our upcoming catalysts and clinical programs position us for significant value creation in 2025." With a clean compliance slate and an advancing clinical portfolio, Hoth is now strategically focused on delivering key milestones across multiple therapeutic areas, including inflammatory diseases, oncology, and rare diseases. About Hoth TherapeuticsHoth Therapeutics, Inc. (NASDAQ: HOTH) is a biopharmaceutical company developing innovative therapies for patients with unmet medical needs. The Company's pipeline includes treatments targeting rare diseases, inflammatory skin disorders, cancer, and neurological conditions. For more information, visit: Forward-Looking StatementThis press release includes forward-looking statements based upon Hoth's current expectations, which may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, and are subject to substantial risks, uncertainties, and assumptions. These statements concern Hoth's business strategies; the timing of regulatory submissions; the ability to obtain and maintain regulatory approval of existing product candidates and any other product candidates we may develop, and the labeling under any approval we may obtain; the timing and costs of clinical trials, and the timing and costs of other expenses; market acceptance of our products; the ultimate impact of the current coronavirus pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems, or the global economy as a whole; our intellectual property; our reliance on third-party organizations; our competitive position; our industry environment; our anticipated financial and operating results, including anticipated sources of revenues; our assumptions regarding the size of the available market, benefits of our products, product pricing, and timing of product launches; management's expectation with respect to future acquisitions; statements regarding our goals, intentions, plans, and expectations, including the introduction of new products and markets; and our cash needs and financing plans. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. You should not place reliance on these forward-looking statements, which include words such as "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" or similar terms, variations of such terms, or the negative of those terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee such outcomes. Hoth may not realize its expectations, and its beliefs may not prove correct. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section titled "Risk Factors" in Hoth's most recent Annual Report on Form 10-K and Hoth's other filings made with the U. S. Securities and Exchange Commission. All such statements speak only as of the date made. Consequently, forward-looking statements should be regarded solely as Hoth's current plans, estimates, and beliefs. Investors should not place undue reliance on forward-looking statements. Hoth cannot guarantee future results, events, levels of activity, performance, or achievements. Hoth does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events, or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law. Investor Contact:LR Advisors LLC Email: investorrelations@ (678) 570-6791 View original content to download multimedia: SOURCE Hoth Therapeutics, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
